Skip to content
Toggle Navigation
COA INITIATIVES
COA Administrators’ Network (CAN)
Community Oncology Pharmacy Association (COPA)
COA Patient Advocacy Network (CPAN)
COA Fellows Initiative
Enhancing Oncology Model Support Network (EOM)
National Cancer Treatment Alliance (NCTA)
Oncology Medical Home (OMH)
EVENTS
Community Oncology Conference
Payer Exchange Summit
State of Community Oncology Briefing
Advocacy Chats
Advocacy Summit
Partner Events
Webinars
All COA Events
GET INVOLVED
Membership
Join Now
Search for:
MyCOA
Toggle Navigation
Education & Publications
COA Prescription
Comment Letters
Studies
Position Statements
Practice Impact Reports
PBM Horror Stories
All Publications
Resources
Professional Networks
COA Quality & Value Standards
Policy Tracker & Maps
Patient Feedback Tools
Practice Benchmarking Software (COAnalyzer)
Addressing PBM & Insurer Abuses
Advocacy
Take Action Center
Patient Advocacy & Education (CPAN)
Sit in My Chair Elected Official Visits
State Legislative Leadership
News & Updates
Latest Updates
Press Releases
Industry News
Newsletters
About
Who We Are
What is Community Oncology?
Board & Leadership
Committees
Contact Us
Cost Savings Potential Associated With the Use of Biosimilars
Published On: June 2nd, 2025
Categories:
Latest News
Page load link
